Prospective longitudinal analysis of antibody response after standard and booster doses of SARS-COV2 vaccination in patients with early breast cancer

Overview of attention for article published in Frontiers in immunology, November 2022

Altmetric Badge

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 4 X posts from 4 X users, with an upper bound of 86,553 followers.

Prospective longitudinal analysis of antibody response after standard and booster doses of SARS-COV2 vaccination in patients with early breast cancer https://t.co/IDMHmeGYa7 https://t.co/O2Qto32AVW

19 Nov 2022

Reply Repost Favourite

RT @BagaiDr: Prospective longitudinal analysis of Abs after standard & booster doses of SARSCOV2 vac in early breast cancer. All participan…

18 Nov 2022

Reply Repost Favourite

Prospective longitudinal analysis of Abs after standard & booster doses of SARSCOV2 vac in early breast cancer. All participants, in BC & in HC group, had⬆️Abs after vac. BC, had weaker humoral responses than HC (IgG: 1.5, 2.3, 2.5-folds in BC vs.

18 Nov 2022

Reply Repost Favourite

New Research: Prospective longitudinal analysis of antibody response after standard and booster doses of SARS-COV2 vaccination in patients with early breast cancer: Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)… https://t.co/gP

18 Nov 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity.